2026 Featured Speakers
OCMF is honored to be featuring speakers from across a number of institutions and disciplines.
Keynote
Ursula Matulonis, MD
Chief of the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School.
Topic: Targeting genomic vulnerabilities to improve ovarian cancer therapeutics
Keynote
Jose Conejo-Garcia, MD, PhD
Chair of the Department of Immunology at H. Lee Moffitt Cancer Research Institute and Professor of Immunology at Duke University School of Medicine.
Topic: Update on the immunobiology of ovarian cancer
Kate Chiappinelli, PhD
Transposable Elements in Ovarian Cancer
George Washington University
Fergus Couch, PhD
BRCA2 Predisposition Mutations
Mayo Clinic
Stephanie Gaillard, MD, PhD
Title TBA
Johns Hopkins
Gordon Mills, MD, PhD
Basic Science and Clinical Advances in Ovarian Cancer
Oregon Health and Science University
Matthew Powell, MD
Recent Clinical Advances in Targeted Treatments for Endometrial Cancers
Washington University School of Medicine
Kathryn R. Taylor, PhD
Neural Activity and its Impact on Cancer Progression
Memorial Sloan Kettering Cancer Center
Jeremy Chien, PhD
Functional Genomic Approaches to Understand Critical Driver Genes
University of California - Davis
Analisa DiFeo, PhD
Treatment Resistance in Ovarian Cancer
University of Michigan School of Medicine
David Mutch, MD
Route 66 SPORE
Washington University School of Medicine
Amy Skubitz, PhD
Ovarian Cancer Early Detection
University of Minnesota
Jordyn Silverstein, MD
Claudin-6 as a novel therapeutic target in ovarian cancer
UCLA
Ashani Weeraratna, PhD
Aging and Cancer
Johns Hopkins
Andrea Wahner Hendrickson, MD
Title TBA
Mayo Clinic